Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Cross-ancestry genetic architecture reveals shared biological pathways of major psychiatric disorders

Abstract

Psychiatric disorders, including bipolar disorder (BD), major depressive disorder (MDD), and schizophrenia (SCZ), share substantial genetic overlap. We conducted a cross-ancestry multivariate genome-wide association study (GWAS) integrating European and East Asian populations to uncover shared genetic underpinnings. Our analyses identified 403 loci associated with shared polygenic liability to psychiatric disorders, including 88 novel regions. Cross-ancestry fine-mapping highlighted robust shared signals, notably at VRK2 (rs7596038), consistently significant across ancestries. Gene prioritization revealed 90 high-confidence candidate genes enriched in neurodevelopmental pathways. Single-nucleus RNA sequencing implicated excitatory neurons and astrocytes as key cellular contexts, emphasizing NCAM1–FGFR1 and NEGR1–NEGR1 signaling pathways. Mendelian randomization analyses provided causal evidence linking shared genetic liability to structural brain alterations, particularly in regions crucial for emotion and cognition. Polygenic risk scores derived from shared genetic liability substantially enhanced predictive accuracy for BD and SCZ, demonstrating strong trans-ancestry validity. These results advance understanding of shared genetic architecture in psychiatric disorders, highlighting potential therapeutic targets and emphasizing the critical importance of diverse ancestry studies in precision psychiatry.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Workflow.
Fig. 2: Polygenic overlaps between distinct psychiatric disorders.
Fig. 3: Cross-ancestry multivariate GWAS of shared liability to BD, MDD, and SCZ in EAS and EUR populations.
Fig. 4: Summary for the enrichment analysis from the top significant genes defined by six gene-level methods.
Fig. 5: Cell-type-specific expression and intercellular signaling mechanisms associated with cross-disorder genetic risk.
Fig. 6: Effect size of genetic liability for BD, MDD, SCZ, and cross-disorder liability.

Similar content being viewed by others

Data availability

The summary statistics of BD, MDD, and SCZ in two ancestries are available here: https://pgc.unc.edu/for-researchers/download-results/.  The summary statistics of eQTL are available from GTEx: https://yanglab.westlake.edu.cn/software/smr/#eQTLsummarydata. The snRNA-seq data is available from https://www.ncbi.nlm.nih.gov/geo/. The gene specificity data per cell type for enrichment analysis is available from https://www.nature.com/articles/s41467-024-55611-1#Sec50. The summary statistics of IDPs are available from here: https://www.ebi.ac.uk/gwas/. The reference panel of two ancestries are available from 1000 Genomes Project: https://www.internationalgenome.org/data/. The UK Biobank data are available to any bona fide researcher following application: https://www.ukbiobank.ac.uk/enable-your-research/apply-for-access. The data of CLASS-BD are available from the corresponding author upon reasonable request.

Code availability

Packages including ‘LAVA’ (version 1.0), ‘GenomicSEM’ (version 0.05), ‘MeSuSiE’ (version 1.0), ‘TwoSampleMR’ (version 0.6.6) and ‘survival’ (version 3.8-3) in R version 4.3.3 were used to perform local genetic correlation, gSEM model, cross-ancestry fine-mapping, Mendelian randomization, and survival analysis. Seurat (version 5.3.0), CellChat (version 2.1.0) in R were used to perform snRNA-seq data processing and cell-cell communication analysis. MiXeR (version 1.2) was used to estimate genetic overlapping. METAL was used to perform GWAS meta-analysis. LDSC (version 1.0.1) were used to perform genetic correlation analysis and enrichment analysis. mBAT (GCTA, version 1.94.1), FUMA, SMR (version 1.4.0), TWAS, PoPS, and PsyOPS were used to identify the pleiotropic genes. DBSLMM (version 1.0), PRS-CSx and PLINK2 were used to estimate in- and cross-ancestry PRS.

References

  1. GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022;9:137–50.

    Article  Google Scholar 

  2. The L. Ensuring care for people with depression. Lancet. 2022;399:885.

    Article  Google Scholar 

  3. Casella CB, Kousoulis AA, Kohrt BA, Bantjes J, Kieling C, Cuijpers P, et al. Data gaps in prevalence rates of mental health conditions around the world: a retrospective analysis of nationally representative data. Lancet Glob Health. 2025;13:e879–e887.

    Article  CAS  PubMed  Google Scholar 

  4. Li HJ, Zhang C, Hui L, Zhou DS, Li Y, Zhang CY, et al. Novel risk loci associated with genetic risk for bipolar disorder among Han Chinese individuals: A genome-wide association study and meta-analysis. JAMA Psychiatry. 2021;78:320–30.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Liu J, Li S, Li X, Li W, Yang Y, Guo S, et al. Genome-wide association study followed by trans-ancestry meta-analysis identify 17 new risk loci for schizophrenia. BMC Med. 2021;19:177.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Li W, Chen R, Feng L, Dang X, Liu J, Chen T, et al. Genome-wide meta-analysis, functional genomics and integrative analyses implicate new risk genes and therapeutic targets for anxiety disorders. Nat Hum Behav. 2024;8:361–79.

    Article  PubMed  Google Scholar 

  7. Jung JY, Ahn Y, Park JW, Jung K, Kim S, Lim S, et al. Polygenic overlap between subjective well-being and psychiatric disorders and cross-ancestry validation. Nat Hum Behav. 2025;9:1272–82.

    Article  PubMed  Google Scholar 

  8. Lam M, Chen CY, Li Z, Martin AR, Bryois J, Ma X, et al. Comparative genetic architectures of schizophrenia in East Asian and European populations. Nat Genet. 2019;51:1670–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Wu Y, Cao H, Baranova A, Huang H, Li S, Cai L, et al. Multi-trait analysis for genome-wide association study of five psychiatric disorders. Transl Psychiatry. 2020;10:209.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Ferreira MA, Purcell SM. A multivariate test of association. Bioinformatics. 2009;25:132–3.

    Article  CAS  PubMed  Google Scholar 

  11. Kim S, Xing EP. Statistical estimation of correlated genome associations to a quantitative trait network. PLoS Genet. 2009;5:e1000587.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Shao K, Luo Z, Huang P, Yang S. ProteoNexus: an integrative database to characterize genetic architecture, estimate mediation effects, and construct and evaluate prediction models of the plasma proteome. Nucleic Acids Res. 2026;54:D1222–d1233.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Turley P, Walters RK, Maghzian O, Okbay A, Lee JJ, Fontana MA, et al. Multi-trait analysis of genome-wide association summary statistics using MTAG. Nat Genet. 2018;50:229–37.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Grotzinger AD, Rhemtulla M, de Vlaming R, Ritchie SJ, Mallard TT, Hill WD, et al. Genomic structural equation modelling provides insights into the multivariate genetic architecture of complex traits. Nat Hum Behav. 2019;3:513–25.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Ray D, Chatterjee N. A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between type 2 diabetes and prostate cancer. PLoS Genet. 2020;16:e1009218.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Mallard TT, Linnér RK, Grotzinger AD, Sanchez-Roige S, Seidlitz J, Okbay A, et al. Multivariate GWAS of psychiatric disorders and their cardinal symptoms reveal two dimensions of cross-cutting genetic liabilities. Cell Genom. 2022;2:100140.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Harkness KL, Stewart JG. Stress and diathesis–stress models in depression. APA handbook of depression: Classification, co-occurring conditions, and etiological processes. 1. Washington, DC, US: American Psychological Association; 2026. p. 441–58.

    Chapter  Google Scholar 

  18. Walker EF, Diforio D. Schizophrenia: A neural diathesis-stress model. Psychol Rev. 1997;104:667–85.

    Article  CAS  PubMed  Google Scholar 

  19. Colodro-Conde L, Couvy-Duchesne B, Zhu G, Coventry WL, Byrne EM, Gordon S, et al. A direct test of the diathesis-stress model for depression. Mol Psychiatry. 2018;23:1590–6.

    Article  CAS  PubMed  Google Scholar 

  20. Levey DF, Galimberti M, Deak JD, Wendt FR, Bhattacharya A, Koller D, et al. Multi-ancestry genome-wide association study of cannabis use disorder yields insight into disease biology and public health implications. Nat Genet. 2023;55:2094–103.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Friligkou E, Løkhammer S, Cabrera-Mendoza B, Shen J, He J, Deiana G, et al. Gene discovery and biological insights into anxiety disorders from a large-scale multi-ancestry genome-wide association study. Nat Genet. 2024;56:2036–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Karlsson Linnér R, Mallard TT, Barr PB, Sanchez-Roige S, Madole JW, Driver MN, et al. Author Correction: Multivariate analysis of 1.5 million people identifies genetic associations with traits related to self-regulation and addiction. Nat Neurosci. 2025;28:213.

    Article  PubMed  Google Scholar 

  23. Akimova ET, Wolfram T, Ding X, Tropf FC, Mills MC. Polygenic prediction of occupational status GWAS elucidates genetic and environmental interplay in intergenerational transmission, careers and health in UK Biobank. Nat Hum Behav. 2025;9:391–405.

    Article  PubMed  Google Scholar 

  24. Ruscio J, Roche B. Determining the number of factors to retain in an exploratory factor analysis using comparison data of known factorial structure. Psychol Assess. 2012;24:282–92.

    Article  PubMed  Google Scholar 

  25. Kaiser HF. The application of electronic computers to factor analysis. Educ Psychol Meas. 1960;20:141–51.

    Article  Google Scholar 

  26. Brown BC, Ye CJ, Price AL, Zaitlen N. Transethnic genetic-correlation estimates from summary statistics. Am J Hum Genet. 2016;99:76–88.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Cao X, Jiang M, Guan Y, Li S, Duan C, Gong Y, et al. Trans-ancestry GWAS identifies 59 loci and improves risk prediction and fine-mapping for kidney stone disease. Nat Commun. 2025;16:3473.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Li Y, Dang X, Chen R, Teng Z, Wang J, Li S, et al. Cross-ancestry genome-wide association study and systems-level integrative analyses implicate new risk genes and therapeutic targets for depression. Nat Hum Behav. 2025;9:806–23.

    Article  PubMed  Google Scholar 

  29. Kircher M, Witten DM, Jain P, O’Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46:310–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Boyle AP, Hong EL, Hariharan M, Cheng Y, Schaub MA, Kasowski M, et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 2012;22:1790–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Kolberg L, Raudvere U, Kuzmin I, Vilo J, Peterson H. gprofiler2 – an R package for gene list functional enrichment analysis and namespace conversion toolset g:Profiler. F1000Res. 2020;9:ELIXIR-709.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Fröhlich AS, Gerstner N, Gagliardi M, Ködel M, Yusupov N, Matosin N, et al. Single-nucleus transcriptomic profiling of human orbitofrontal cortex reveals convergent effects of aging and psychiatric disease. Nat Neurosci. 2024;27:2021–32.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Gerstner N, Fröhlich AS, Matosin N, Gagliardi M, Cruceanu C, Ködel M, et al. Contrasting genetic predisposition and diagnosis in psychiatric disorders: A multi-omic single-nucleus analysis of the human OFC. Sci Adv. 2025;11:eadq2290.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Zhang YQ, Zhang Q, Yang Y, Yu LL, Fan NL, Wu Y, et al. Elevated NEGR1 in brain induces anxiety or depression-like phenotypes and synaptic dysfunction. Mol Psychiatry. 2025;30:4627–40.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Richards AL, Cardno A, Harold G, Craddock NJ, Di Florio A, Jones L, et al. Genetic liabilities differentiating bipolar disorder, schizophrenia, and major depressive disorder, and phenotypic heterogeneity in bipolar disorder. JAMA Psychiatry. 2022;79:1032–9.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Grotzinger AD, Mallard TT, Akingbuwa WA, Ip HF, Adams MJ, Lewis CM, et al. Genetic architecture of 11 major psychiatric disorders at biobehavioral, functional genomic and molecular genetic levels of analysis. Nat Genet. 2022;54:548–59.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Ahangari M, Kirkpatrick R, Nguyen T-H, Gillespie N, Consortium ISG, Kendler KS, et al. Examining the source of increased bipolar disorder and major depressive disorder common risk variation burden in multiplex schizophrenia families. Schizophr. 2022;8:106.

  38. Zerbin‐Rüdin E, Kendler KS. Ernst Rüdin (1874-1952) and his genealogic-demographic department in Munich (1917-1986): an introduction to their family studies of schizophrenia. Am J Med Genet. 1996;67:332–7.

    Article  PubMed  Google Scholar 

  39. ENCODE Project Consortium, A. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489:57–74.

    Article  Google Scholar 

  40. Li M, Yue W. VRK2, a candidate gene for psychiatric and neurological disorders. Mol Neuropsychiatry. 2018;4:119–33.

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Steinberg S, de Jong S, Andreassen OA, Werge T, Børglum AD, Mors O, et al. Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Hum Mol Genet. 2011;20:4076–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Xiao X, Luo XJ, Chang H, Liu Z, Li M. Evaluation of European schizophrenia GWAS Loci in Asian populations via comprehensive meta-analyses. Mol Neurobiol. 2017;54:4071–80.

    Article  CAS  PubMed  Google Scholar 

  43. Chang H, Zhang C, Xiao X, Pu X, Liu Z, Wu L, et al. Further evidence of VRK2 rs2312147 associated with schizophrenia. World J Biol Psychiatry. 2016;17:457–66.

    Article  PubMed  Google Scholar 

  44. Hyde CL, Nagle MW, Tian C, Chen X, Paciga SA, Wendland JR, et al. Identification of 15 genetic loci associated with risk of major depression in individuals of European descent. Nat Genet. 2016;48:1031–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Stahl EA, Breen G, Forstner AJ, McQuillin A, Ripke S, Trubetskoy V, et al. Genome-wide association study identifies 30 loci associated with bipolar disorder. Nat Genet. 2019;51:793–803.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Nagel M, Jansen PR, Stringer S, Watanabe K, de Leeuw CA, Bryois J, et al. Meta-analysis of genome-wide association studies for neuroticism in 449,484 individuals identifies novel genetic loci and pathways. Nat Genet. 2018;50:920–7.

    Article  CAS  PubMed  Google Scholar 

  47. Howes OD, Onwordi EC. The synaptic hypothesis of schizophrenia version III: A master mechanism. Mol Psychiatry. 2023;28:1843–56.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Pardiñas AF, Holmans P, Pocklington AJ, Escott-Price V, Ripke S, Carrera N, et al. Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection. Nat Genet. 2018;50:381–9.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Zhou J, Ma C, Wang K, Li X, Zhang H, Chen J, et al. Rare and common variants analysis of the EMB gene in patients with schizophrenia. BMC Psychiatry. 2020;20:135.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Newton S, Aguilar C, Bunton-Stasyshyn RK, Flook M, Stewart M, Marcotti W, et al. Absence of Embigin accelerates hearing loss and causes sub-viability, brain and heart defects in C57BL/6N mice due to interaction with Cdh23(ahl). iScience. 2023;26:108056.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Wilson MC, Meredith D, Fox JE, Manoharan C, Davies AJ, Halestrap AP. Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4: the ancillary protein for the insensitive MCT2 is EMBIGIN (gp70). J Biol Chem. 2005;280:27213–21.

    Article  CAS  PubMed  Google Scholar 

  52. Bledsoe X, Gamazon ER. A transcriptomic atlas of the human brain reveals genetically determined aspects of neuropsychiatric health. Am J Hum Genet. 2024;111:1559–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Kiselyov VV, Skladchikova G, Hinsby AM, Jensen PH, Kulahin N, Soroka V, et al. Structural basis for a direct interaction between FGFR1 and NCAM and evidence for a regulatory role of ATP. Structure. 2003;11:691–701.

    Article  CAS  PubMed  Google Scholar 

  54. Stark C, Breitkreutz BJ, Reguly T, Boucher L, Breitkreutz A, Tyers M. BioGRID: a general repository for interaction datasets. Nucleic Acids Res. 2006;34:D535–539.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Životić M, Tampe B, Müller G, MÃMüller C, Lipkovski A, Xu X, et al. Modulation of NCAM/FGFR1 signaling suppresses EMT program in human proximal tubular epithelial cells. PLoS ONE. 2018;13:e0206786.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Shukrun R, Golan H, Caspi R, Pode-Shakked N, Pleniceanu O, Vax E, et al. NCAM1/FGF module serves as a putative pleuropulmonary blastoma therapeutic target. Oncogenesis. 2019;8:48.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Habicher J, Sanvido I, Buehler A, Sartori S, Piccoli G, Carl M. The risk genes for neuropsychiatric disorders negr1 and opcml are expressed throughout zebrafish brain development. Genes (Basel). 2024;15:363.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Pischedda F, Szczurkowska J, Daniela Cirnaru M, Cancedda L, Piccoli G The role of Negr1 in cortical development via NCAM-FGFR2 signaling. LID - P38. (2193-1801 (Electronic)).

  59. Lipsky RK, Garrett ME, Dennis MF, Hauser MA, Beckham JC, Ashley-Koch AE, et al. Impact of traumatic life events and polygenic risk scores for major depression and posttraumatic stress disorder on Iraq/Afghanistan Veterans. J Psychiatr Res. 2023;158:15–19.

    Article  PubMed  Google Scholar 

  60. Thorp JG, Gerring ZF, Colodro-Conde L, Byrne EM, Medland SE, Middeldorp CM, et al. The association between trauma exposure, polygenic risk and individual depression symptoms. Psychiatry Res. 2023;321:115101.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Vilhjálmsson BJ, Yang J, Finucane HK, Gusev A, Lindström S, Ripke S, et al. Modeling linkage disequilibrium increases accuracy of polygenic risk scores. Am J Hum Genet. 2015;97:576–92.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Ge T, Chen CY, Ni Y, Feng YA, Smoller JW. Polygenic prediction via Bayesian regression and continuous shrinkage priors. Nat Commun. 2019;10:1776.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Zhao Z, Fritsche LG, Smith JA, Mukherjee B, Lee S. The construction of cross-population polygenic risk scores using transfer learning. Am J Hum Genet. 2022;109:1998–2008.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Meng X, Navoly G, Giannakopoulou O, Levey DF, Koller D, Pathak GA, et al. Multi-ancestry genome-wide association study of major depression aids locus discovery, fine mapping, gene prioritization and causal inference. Nat Genet. 2024;56:222–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Guo X, Feng Y, Ji X, Jia N, Maimaiti A, Lai J, et al. Shared genetic architecture and bidirectional clinical risks within the psycho-metabolic nexus. EBioMedicine. 2025;111:105530.

    Article  CAS  PubMed  Google Scholar 

  66. O’Connell KS, Koromina M, van der Veen T, Boltz T, David FS, Yang JMK, et al. Genomics yields biological and phenotypic insights into bipolar disorder. Nature. 2025;639:968–75.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Palmer LJ. UK Biobank: Bank on it. Lancet. 2007;369:1980–2.

    Article  PubMed  Google Scholar 

  68. Cao C, Zhang S, Wang J, Tian M, Ji X, Huang D, et al. PGS-Depot: a comprehensive resource for polygenic scores constructed by summary statistics based methods. Nucleic Acids Res. 2024;52:D963–d971.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Yang S, Zhou X. Accurate and scalable construction of polygenic scores in large biobank data sets. Am J Hum Genet. 2020;106:679–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Yang S, Ye X, Ji X, Li Z, Tian M, Huang P, et al. PGSFusion streamlines polygenic score construction and epidemiological applications in biobank-scale cohorts. Genome Med. 2025;17:77.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Li Z, Lai J, Zhang P, Ding J, Jiang J, Liu C, et al. Multi-omics analyses of serum metabolome, gut microbiome and brain function reveal dysregulated microbiota-gut-brain axis in bipolar depression. Mol Psychiatry. 2022;27:4123–35.

    Article  CAS  PubMed  Google Scholar 

  72. Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, et al. A global reference for human genetic variation. Nature. 2015;526:68–74.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Cong PK, Bai WY, Li JC, Yang MY, Khederzadeh S, Gai SR, et al. Genomic analyses of 10,376 individuals in the Westlake BioBank for Chinese (WBBC) pilot project. Nat Commun. 2022;13:2939.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Greenberg A, Reynolds K, McNulty MT, Sampson MG, Kang HM, Lee D Accurate cross-platform GWAS analysis via two-stage imputation. medRxiv: 2024.2004.2019.24306081 [Preprint] 2024. https://www.medrxiv.org/content/10.1101/2024.04.19.24306081v1.

  75. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559–75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Frei O, Holland D, Smeland OB, Shadrin AA, Fan CC, Maeland S, et al. Bivariate causal mixture model quantifies polygenic overlap between complex traits beyond genetic correlation. Nat Commun. 2019;10:2417.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Holland D, Frei O, Desikan R, Fan CC, Shadrin AA, Smeland OB, et al. Beyond SNP heritability: Polygenicity and discoverability of phenotypes estimated with a univariate Gaussian mixture model. PLoS Genet. 2020;16:e1008612.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Liu M, Wang L, Zhang Y, Dong H, Wang C, Chen Y, et al. Investigating the shared genetic architecture between depression and subcortical volumes. Nat Commun. 2024;15:7647.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Werme J, van der Sluis S, Posthuma D, de Leeuw CA. An integrated framework for local genetic correlation analysis. Nat Genet. 2022;54:274–82.

    Article  CAS  PubMed  Google Scholar 

  80. Bulik-Sullivan BK, Loh PR, Finucane HK, Ripke S, Yang J, Patterson N, et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat Genet. 2015;47:291–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Schoeler T, Baldwin J, Allegrini A, Barkhuizen W, McQuillin A, Pirastu N, et al. Novel biological insights into the common heritable liability to substance involvement: A multivariate genome-wide association study. Biol Psychiatry. 2023;93:524–35.

    Article  CAS  Google Scholar 

  82. Willer CJ, Li Y, Abecasis GR. METAL: Fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 2010;26:2190–1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Gao B, Zhou X. MESuSiE enables scalable and powerful multi-ancestry fine-mapping of causal variants in genome-wide association studies. Nat Genet. 2024;56:170–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Li A, Liu S, Bakshi A, Jiang L, Chen W, Zheng Z, et al. mBAT-combo: A more powerful test to detect gene-trait associations from GWAS data. Am J Hum Genet. 2023;110:30–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. Watanabe K, Taskesen E, van Bochoven A, Posthuma D. Functional mapping and annotation of genetic associations with FUMA. Nat Commun. 2017;8:1826.

    Article  PubMed  PubMed Central  Google Scholar 

  86. Gusev A, Ko A, Shi H, Bhatia G, Chung W, Penninx BW, et al. Integrative approaches for large-scale transcriptome-wide association studies. Nat Genet. 2016;48:245–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. Zhu Z, Zhang F, Hu H, Bakshi A, Robinson MR, Powell JE, et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat Genet. 2016;48:481–7.

    Article  CAS  PubMed  Google Scholar 

  88. Weeks EM, Ulirsch JC, Cheng NY, Trippe BL, Fine RS, Miao J, et al. Leveraging polygenic enrichments of gene features to predict genes underlying complex traits and diseases. Nat Genet. 2023;55:1267–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. Wainberg M, Merico D, Keller MC, Fauman EB, Tripathy SJ. Predicting causal genes from psychiatric genome-wide association studies using high-level etiological knowledge. Mol Psychiatry. 2022;27:3095–106.

    Article  PubMed  Google Scholar 

  90. Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan CH, et al. Inference and analysis of cell-cell communication using CellChat. Nat Commun. 2021;12:1088.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  91. Finucane HK, Bulik-Sullivan B, Gusev A, Trynka G, Reshef Y, Loh PR, et al. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat Genet. 2015;47:1228–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  92. Bryois J, Skene NG, Hansen TF, Kogelman LJA, Watson HJ, Liu Z, et al. Genetic identification of cell types underlying brain complex traits yields insights into the etiology of Parkinson’s disease. Nat Genet. 2020;52:482–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  93. Yao S, Harder A, Darki F, Chang YW, Li A, Nikouei K, et al. Connecting genomic results for psychiatric disorders to human brain cell types and regions reveals convergence with functional connectivity. Nat Commun. 2025;16:395.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  94. Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-Base platform supports systematic causal inference across the human phenome. eLife. 2018;7:e34408.

    Article  PubMed  PubMed Central  Google Scholar 

  95. Fu J, Zhang Q, Wang J, Wang M, Zhang B, Zhu W, et al. Cross-ancestry genome-wide association studies of brain imaging phenotypes. Nat Genet. 2024;56:1110–20.

    Article  CAS  PubMed  Google Scholar 

  96. Ruan Y, Lin YF, Feng YA, Chen CY, Lam M, Guo Z, et al. Improving polygenic prediction in ancestrally diverse populations. Nat Genet. 2022;54:573–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Yang S, Zhou X. PGS-server: accuracy, robustness and transferability of polygenic score methods for biobank scale studies. Brief Bioinform. 2022;23:bbac039.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank the GWAS Catalog, the Psychiatric Genomics Consortium, 1000 Genomes Project, and UK Biobank (Application 144904) for access to genome-wide association study data, and all research participants who provided DNA samples for these studies.

Funding

The study was supported by funding from the National Natural Science Foundation of China (82571735, 82173585), Key R&D Program of Zhejiang Province (2024C03098, 2025C02109), and The National Key Research and Development Program of China (2023YFC2506200, 2023YFC2506203).

Author information

Authors and Affiliations

Authors

Contributions

S.H. and S.Y. conceived and designed the study. Y.F., N.J., and P.H. analyzed the data. Y.F., N.J., and P.H. interpreted the findings. Y.F., S.Y., and S.H. drafted or substantively revised the paper.

Corresponding authors

Correspondence to Shaohua Hu or Sheng Yang.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval and consent to participate

Ethical approval of UK Biobank study was granted by the National Health Service National Research Ethics Service (reference 11/NW/0382). Ethical approval of Chinese Longitudinal and Systematic Study of Bipolar Disorder was granted by the Medical Research Ethics Committee, and all participants provided written informed consent (Approval number: 2017-397). Written informed consent was secured from all participants and their legal guardians before they were enrolled in the study. It was a single-center study conducted at the First Affiliated Hospital, Zhejiang University School of Medicine (Clinical trial registration number: NCT05480150). All methods were performed in accordance with the relevant guidelines and regulations.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Feng, Y., Jia, N., Huang, P. et al. Cross-ancestry genetic architecture reveals shared biological pathways of major psychiatric disorders. Mol Psychiatry (2026). https://doi.org/10.1038/s41380-026-03541-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Version of record:

  • DOI: https://doi.org/10.1038/s41380-026-03541-3

Search

Quick links